1. Home
  2. PRAX

as 10-17-2024 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.

Founded: 2015 Country:
United States
United States
Employees: N/A City: BOSTON
Market Cap: 1.2B IPO Year: 2020
Target Price: $144.11 AVG Volume (30 days): 295.5K
Analyst Decision: Strong Buy Number of Analysts: 9
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -9.72 EPS Growth: N/A
52 Week Low/High: $13.01 - $75.73 Next Earning Date: 11-05-2024
Revenue: $1,771,000 Revenue Growth: 20.97%
Revenue Growth (this year): -38.95% Revenue Growth (next year): -35.21%

PRAX Daily Stock ML Predictions

Share on Social Networks: